Affirm Stock: Take Your Medicine (NASDAQ:AFRM)
Drew Angerer Investment Thesis Affirm (NASDAQ:NASDAQ:AFRM) needs to take its medicine. There’s already enough evidence in the market to reflect both the positive and negative elements facing Affirm. My bull case for Affirm is that […]
